A call to action for deciphering genetic variants in human pluripotent stem cells for cell therapy

Nissim Benvenisty, Jonathan S. Draper, Paul J. Gokhale, Lyn Healy, Zoe Hewitt, Deborah Hursh, Adam Hodgson, Tenneille E. Ludwig, Nancy Mah, Sarah E. McClelland, Milena Mennecozzi, Florian T. Merkle, Joanne C. Mountford, Martin Pera, Alessandro Prigione, Tristan A. Rodriguez, Andrea Rossi, Foad J. Rouhani, Kourosh Saeb-Parsy, Lucia Selfa AspirozNika Shakiba, Claudia Spits, Peter D. Tonge, Ivana Barbaric

Research output: Contribution to journalComment/debate

Abstract

Human pluripotent stem cell (hPSC)-based therapies offer promise but pose potential risks due to culture-acquired genetic variants, some of which have been linked with cancer. An international workshop addressed these concerns, highlighting the need for improved strategies to stratify variants and chart a path toward definitive guidelines in hPSC-based therapy.

Original languageEnglish
Pages (from-to)508-512
Number of pages5
JournalCell Stem Cell
Volume32
Issue number4
DOIs
StatePublished - 3 Apr 2025

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Genetics
  • Cell Biology

Fingerprint

Dive into the research topics of 'A call to action for deciphering genetic variants in human pluripotent stem cells for cell therapy'. Together they form a unique fingerprint.

Cite this